Search
-
Antiviral activity of S/GSK1349572, the only once-daily, unboosted integrase inhibitor in clinical development, evaluated in phase 2 study
Media
GSK announced results from Phase 2a study evaluating antiviral activity of INI, S/GSK1349572, results presented at IAS Conference.
https://www.gsk.com/en-gb/media/press-releases/antiviral-activity-of-sgsk1349572-the-only-once-daily-unboosted-integrase-inhibitor-in-clinical-development-evaluated-in-phase-2-study/
First published: 20 July 2009
-
Antiviral Activity of S/GSK1265744, a Once-Daily, Unboosted Integrase Inhibitor in Clinical Development, Evaluated in Phase 1-2a Study in Healthy and HIV-Infected Subjects
Media
GSK announced results from Phase 1-2a study evaluating PK, safety and activity of its INI S/GSK1265744 in healthy HIV-infected patients.
https://www.gsk.com/en-gb/media/press-releases/antiviral-activity-of-sgsk1265744-a-once-daily-unboosted-integrase-inhibitor-in-clinical-development-evaluated-in-phase-1-2a-study-in-healthy-and-hiv-infected-subjects/
First published: 13 September 2009
-
Understanding our value chain water footprint
Media
https://www.gsk.com/media/9374/understanding-our-value-chain-water-footprint.pdf
First published: 25 July 2022
-
Pandemic preparedness policy
Media
https://www.gsk.com/media/2951/pandemic-preparedness-policy.pdf
First published: 26 November 2019
-
Incremental innovation policy
Media
https://www.gsk.com/media/2943/incremental-innovation-policy.pdf
First published: 14 May 2019
-
Press Release GSK Receives US FDA Fast Track Designation For Bepirovirsen
Media
https://www.gsk.com/media/10957/press-release-gsk-receives-us-fda-fast-track-designation-for-bepirovirsen.pdf
First published: 12 February 2024
-
GSK Receives US FDA Fast Track Designation For Bepirovirsen Press Release
Media
https://www.gsk.com/media/10959/gsk-receives-us-fda-fast-track-designation-for-bepirovirsen-press-release.pdf
First published: 12 February 2024
-
Press Release Tony Wood Appointed Chief Scientific Officer Designate, GSK
Media
https://www.gsk.com/media/7358/press-release-tony-wood-appointed-chief-scientific-officer-designate-gsk.pdf
First published: 19 January 2022
-
Hiv Analyst Call Presentation
Media
https://www.gsk.com/media/8167/hiv-analyst-call-presentation.pdf
First published: 06 June 2022
-
HIV analyst call presentation
Media
https://www.gsk.com/media/3505/hiv-analyst-call-presentation.pdf
First published: 26 February 2017